2027 Diagnostics & Early Detection Innovation Award

Earlier Detection for Clearer Answers and Better Outcomes.

The 2027 HealthTechNode Diagnostics & Early Detection Innovation Award recognizes technologies, tests, platforms, devices, and care approaches that improve how health conditions are identified, assessed, and understood. This award honors innovations that enable earlier detection, greater diagnostic accuracy, faster answers, and more informed clinical decisions.

Timely and reliable diagnosis can shape every step that follows. Advances in imaging, biomarkers, laboratory testing, AI, point-of-care devices, screening, and clinical decision support can help identify risk sooner, reduce uncertainty, and connect patients with appropriate care.

This award celebrates solutions demonstrating analytical strength and practical healthcare value. Strong entries will show how the innovation improves detection, accuracy, turnaround time, access, clinical workflows, patient experience, or measurable outcomes.

Entry Schedule

• Entries Open: November 16, 2027
• Early Bird Deadline: December 10, 2027
• Final Entry Deadline: January 7, 2028
• Winners Announced: January 24, 2028

Entry Fees

• Early Bird Entry: $395
• Regular Entry: $495

Who Should Enter

• Companies developing diagnostic tests, devices, imaging, screening, or laboratory technologies
• Organizations advancing biomarkers, AI-enabled diagnostics, or clinical decision support
• Teams improving point-of-care testing, early detection, or risk identification
• Health systems and partners implementing innovative diagnostic workflows
• Companies demonstrating measurable analytical, clinical, operational, or patient value

What Judges Will Consider

• Demonstrated value in improving detection, diagnostic accuracy, speed, access, or outcomes
• Strength of the scientific foundation, innovation, usability, and implementation approach
• Evidence of analytical performance, clinical utility, adoption, or measurable impact
• Ability to support responsible use across real-world diagnostic settings
• Clear differentiation within the diagnostics and early detection landscape

Eligibility

• Open to companies, startups, organizations, and teams operating in health technology worldwide
• Entries should highlight work developed, released, updated, expanded, or significantly advanced during 2027
• Submissions should include supporting evidence that clearly demonstrates the innovation’s value and impact

Entry fees are charged at submission and are non-refundable. Customer or client identity should be included in your submission. If you need names excluded from public materials, notify us in writing at the time of submission. By submitting, you agree to the Submission Guidelines, Privacy Policy, and Terms and Conditions. HealthTechNode Awards are independent and unaffiliated with other award programs.